Grant of options

RNS Number : 7678O

Synairgen plc

22 September 2011

Synairgen plc ('Synairgen' or the 'Company')

Grant of options

On 21 September 2011 the board of Synairgen granted options ("Options") over 2,126,469 ordinary shares of one pence each in the capital of the Company ("Ordinary Shares") at an exercise price of one pence per Ordinary Share. The Options represent in aggregate 3.06 per cent. of the existing issued share capital.

The Options are issued under the Company's existing Long Term Incentive Plan and are exercisable between 21 September 2014 and 20 September 2021, subject to achievement of performance criteria related to the increase in the total shareholder return of the Company.

The following Options were issued to directors of the Company on 21 September 2011:

Director	Options Issued
Richard Marsden	538,063
John Ward	489,148
Dr. Phillip Monk	400,212

Following the issue of the Options, the interests of the directors of the Company at 21 September 2011 are as follows:

Director	Total Options Issued	Ordinary Shares	Total Interest	% of issued share capital
Richard Marsden	2,342,032	95,860	2,437,892	3.50%
John Ward	1,772,756	228,788	2,001,544	2.88%
Dr. Phillip Monk	1,235,971	18,518	1,254,489	1.80%
Iain Buchanan	212,765	92,592	305,357	0.44%
Dr. David Campbell	-	253,960	253,960	0.37%
Paul Clegg	250,000	184,095	434,095	0.62%
Prof. Stephen Holgate (Note 1)	-	852,316	852,316	1.23%
Simon Shaw	-	1,368,580	1,368,580	1.97%